The Fort Worth oncology company tapped former Salarius Pharmaceuticals CEO David Arthur to lead its push toward commercialization, including a planned IND for a rare pediatric brain cancer program.
Ribbon-cutting ceremony for the National Center for Therapeutics Manufacturing satellite campus [Photo: UTA]